NasdaqCM:MBOTMedical Equipment
Evaluating Microbot Medical’s Valuation Following FDA Clearance of LIBERTY Endovascular Robotic System
Microbot Medical has grabbed the spotlight with news that could shift the company’s direction in a major way. After securing FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, the first single-use, remotely operated device approved for peripheral endovascular procedures, the company is now cleared to commercialize this breakthrough technology in the U.S. market. By removing the typical hurdles of expensive capital equipment and specialized infrastructure, LIBERTY could give...